Evidence map›Paper›PMID 42095817›Full record

ReviewAging2026

Cellular senescence: from pathogenic mechanisms to precision anti-aging interventions.

Jian Deng, Ruipu Sun, Zhiyong Bai, Lisha Fang, Xudong Zhao, Dong Yang

Abstract readReview
PubMed Publisher
In one paragraph

Review in Aging, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Jian DengDepartment of Targeting Therapy and Immunology and Laboratory of Cell Engineering and Immunotherapy, Cancer Center and State Key Laboratory of Respiratory Health and Multimorbidity and Frontiers Science Center for Disease-Related Molecular Network, West China Hospital, Sichuan University, Chengdu, Sichuan, China.
Ruipu SunDepartment of Targeting Therapy and Immunology and Laboratory of Cell Engineering and Immunotherapy, Cancer Center and State Key Laboratory of Respiratory Health and Multimorbidity and Frontiers Science Center for Disease-Related Molecular Network, West China Hospital, Sichuan University, Chengdu, Sichuan, China.
Zhiyong BaiDepartment of Targeting Therapy and Immunology and Laboratory of Cell Engineering and Immunotherapy, Cancer Center and State Key Laboratory of Respiratory Health and Multimorbidity and Frontiers Science Center for Disease-Related Molecular Network, West China Hospital, Sichuan University, Chengdu, Sichuan, China.
Lisha FangDepartment of Targeting Therapy and Immunology and Laboratory of Cell Engineering and Immunotherapy, Cancer Center and State Key Laboratory of Respiratory Health and Multimorbidity and Frontiers Science Center for Disease-Related Molecular Network, West China Hospital, Sichuan University, Chengdu, Sichuan, China.
Xudong ZhaoDepartment of Targeting Therapy and Immunology and Laboratory of Cell Engineering and Immunotherapy, Cancer Center and State Key Laboratory of Respiratory Health and Multimorbidity and Frontiers Science Center for Disease-Related Molecular Network, West China Hospital, Sichuan University, Chengdu, Sichuan, China.
Dong YangDepartment of Targeting Therapy and Immunology and Laboratory of Cell Engineering and Immunotherapy, Cancer Center and State Key Laboratory of Respiratory Health and Multimorbidity and Frontiers Science Center for Disease-Related Molecular Network, West China Hospital, Sichuan University, Chengdu, Sichuan, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

For decades, research on cellular senescence has predominantly focused on the static identification of senescent cells using markers such as p16 and β-galactosidase, largely overlooking their functional heterogeneity across spatiotemporal dimensions. Accumulating evidence reveals that senescent cells are not merely deleterious pathological byproducts; rather, a subset plays indispensable physiological roles in embryonic development, wound healing, and the maintenance of tissue homeostasis. Based on these insights, this review summarizes the induction mechanisms of cellular senescence and the subsequent evolution of their functional phenotypes across diverse tissues. Consequently, we propose a novel paradigm for senescence management centered on "prevention first, followed by precision intervention." This strategy involves, on one hand, mitigating environmental stressors and optimizing metabolism to intercept the onset of detrimental senescence at its source. On the other hand, it advocates for the functional profiling of existing senescent populations via single-cell omics and lineage tracing, enabling the targeted clearance of "maladaptive" components that drive pathological phenotypes while preserving "beneficial" elements essential for physiological stability. Such a systematic intervention, grounded in the classification of induction factors and functional subtypes, offers a safer and more efficacious trajectory for the prevention of age-related diseases and the extension of healthspan.

Indexed as

AgingCellular SenescenceAnimalsHumansaging mechanismscellular senescencefunctional heterogeneityprecision anti-aging

Identifiers

PMID42095817

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.